Stimulation of melanogenesis in a human melanoma cell line by bistratene A

Biochemical Pharmacology

Volumn 55, Issue 10, 1998, Pages 1691-1699

  Watters, Dianne ^a   Garrone, Bernadette ^a   Coomer, Joanne ^a   Johnson, W Eustace ^b   Brown, Geoffrey ^b   Parsons, Peter ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

Bistratene A; Cell cycle; Melanogenesis; Protein kinase C delta; Stathmin

Indexed keywords

BISTRATENE A; MELANIN; MESSENGER RNA; MONOPHENOL MONOOXYGENASE; PROTEIN KINASE C; STATHMIN;

ARTICLE; CANCER CELL CULTURE; CELL CYCLE G2 PHASE; CELL DIFFERENTIATION; CELL STRUCTURE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE TRANSLOCATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; MELANOGENESIS; MELANOMA CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

EID: 0032525254     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00680-1     Document Type: Article

References (54)

1. Kwon BS, Haq AK, Wakulchik M, Kestler D, Barton DE, Franke U, Lamoroux ML, Whitney JB, Halaban R. Isolation, chromosomal mapping and expression of the mouse tyrosinase gene. J. Invest. Dermatol. 93:1989;589-594.
2. Jackson IJ. A cDNA encoding tyrosinase-related protein maps to the brown locus in mice. Proc. Natl. Acad. Sci. USA. 85:1988;4392-4396.
3. Jackson IJ, Chambers DM, Tsukamoto K, Copeland NG, Gilbert DJ, Jenkins NA, Hearing V. A second tyrosinase-related protein, TRP-2 maps to and is mutated at the mouse slaty locus. EMBO J. 11:1992;527-536.
4. Kobayashi T, Urabe K, Orlow SJ, Higashi K, Imokawa G, Kwon BS, Potter B, Hearing VJ. The Pmel 17/silver locus protein. Characterization and investigation of its melanogenic function. J. Biol. Chem. 269:1994;29198-29205.
5. Kwon BS. Pigmentation genes the tyrosinase gene family and the Pmel17 gene family . J. Invest. Dermatol. 100:(Suppl):1993;134S-140S.
6. Kwon BS, Halaban R, Kim GS, Pomerantz S, Haq AK. A melanocyte specific cDNA clone whose expression is inducible by MSH and IBMX. Mol. Biol. Med. 4:1987;339-356.
7. Gordon PR, Gilchrest BA. Human melanogenesis is stimulated by diacylglycerol. J. Invest. Dermatol. 93:1989;700-702.
8. Park H-Y, Russakovsky V, Ohno S, Gilchrest BA. The β-isoform of protein kinase C stimulates human melanogenesis by activating tyrosinase in pigment cells. J. Biol. Chem. 268:1993;11742-11749.
9. Park H-Y, Russakovsky V, Ao Y, Fernandez E, Gilchrest BA. Alpha-melanocyte stimulating hormone-induced pigmentation is blocked by depletion of protein kinase C. Exp. Cell Res. 227:1996;70-79.
10. Mahalingam H, Vaughn J, Novotny J, Gruber JR, Niles RM. Regulation of melanogenesis in B16 mouse melanoma cells by protein kinase C. J. Cell. Physiol. 168:1996;549-558.
11. Powell MB, Rosenberg RK, Graham MJ, Birch M, Yamanishi DT, Buckmeier JA, Meyskens FL Jr. Protein kinase C β expression in melanoma cells and melanocytes: differential expression correlates with biologic responses to 12-O-tetradecanoylphorbol 13 acetate. J. Cancer Res. Clin. Oncol. 119:1993;199-206.
12. Yamanishi DT, Meyskens JR. Alterations in gene expression and signal transductions in human melanocytes and melanoma cells. Crit. Rev. Oncogen. 5:1994;429-450.
13. Brooks G, Goss MW, East JA, Hart IR. Growth of melanocytic cells is associated with down-regulation of protein kinase C α, δ and ε isoforms. J. Biol. Chem. 268:1993;23868-23875.
14. Liu B, Renaud C, Nilson KK, Chen YQ, Bazaz R, Kowynia J, Timar J, Diglio CA, Honn KV. Protein kinase C inhibitor calphostin C reduces B16 amelanotic melanoma cell adhesion to endothelium and lung colonisation. Int. J. Cancer. 52:1992;147-152.
15. Griffiths G, Garrone B, Deacon E, Pongracz J, Owen P, Meade G, Watters D, Lord J. The polyether Bistratene, A activates protein kinase C-δ and induces growth arrest in HL-60 cells. Biochem. Biophys. Res. Commun. 222:1996;802-808.
16. Degnan B, Hawkins CJ, Lavin MF, McCaffrey E, Parry D, Watters D. Novel cytotoxic compounds from the ascidian Lissoclinum bistratum. J. Med. Chem. 32:1989;1355-1359.
17. Whitehead R, Little JH. Tissue culture studies on human malignant melanoma. Pigment Cell. 1:1973;289-382.
18. Maynard K, Parsons PG. Cross-sensitivity of methylating agents, hydroxyurea, and methotrexate in human tumour cells of the MER-phenotype. Cancer Res. 46:1986;5009-5013.
19. Chen TR. In situ detection of mycoplasma contamination in cell culture by fluorescent Hoechst 33258 stain. Exp. Cell Res. 104:1977;255-262.
20. Oka M, Ando H, Kikkawa U, Ichihashi M. Differential down-regulation of Protein kinase C subspecies in normal human melanocytes possible involvement of the ζ subspecies in growth regulation . J. Invest. Dermatol. 105:1995;567-571.
21. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning, a laboratory manual. 2nd ed. 1989;Cold Spring Harbour Laboratory Press, New York.
22. Cohen T, Muller RM, Tomita Y, Shibahara S. cDNA encoding human tyrosinase-related protein. Nucleic Acid Res. 18:1990;2807-2808.
23. Kwon BS, Haq AK, Pomerantz SH, Halaban R. Isolation and sequence of a cDNA clone for human tyrosinase that maps at the mouse c-albino locus. Proc. Natl. Acad. Sci. USA. 84:1987;7473-7477.
24. Kwon BS, Chintamaneni C, Kozak CA, Copeland NG, Gilbert DJ, Jenkins N, Barton D, Francke U, Kobayashi Y, Kim YY. A melanocyte-specific gene pmel17, maps near the silver coat color locus on mouse chromosome 10 and is in a syntenic region on human chromosome 12. Proc. Natl. Acad. Sci. USA. 88:1991;9228-9232.
25. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren J, Bokesch H, Kenney S, Boyd M. New colorimetric cytotoxicity assay for anti-cancer drug screening. J. Natl. Cancer Inst. 82:1990;1107-1112.
26. Watters D, Beamish H, Marshall K, Gardiner R, Seymour G, Lavin M. Accumulation of HL-60 leukemia cells in G2/M and inhibition of cytokinesis caused by two marine compounds, bistratene A and cycloxazoline. Cancer Chemother. and Pharmacol. 33:1994;399-409.
27. Watters DJ, Michael J, Hemphill J, Hamilton SE, Lavin MF, Pettit GR. A novel compound causing changes in protein phosphorylation patterns in human leukemia cells. J. Cell. Biochem. 49:1992;417-424.
28. Beretta L, Dobransky T, Sobel A. Multiple phosphorylation of stathmin. J. Biol. Chem. 268:1993;20076-20084.
29. Watters D, Garrone B, Gobert G, Williams S, Gardiner R, Lavin M. Bistratene A causes phosphorylation of talin and redistribution of actin microfilaments in fibroblasts: possible role for PKC-δ Exp. Cell Res. 229:1996;327-335.
30. Takahashi H, Parsons PG. In vitro phenotypic alteration of human melanoma cells induced by differentiating agents heterogeneous effects on cellular growth and morphology, enzymatic activity and antigenic expression . Pigment Cell Res. 3:1990;223-232.
31. Vijayasaradhi S, Doskoch PM, Houghton AN. Biosynthesis and intracellular movement of the melanoma membrane glycoprotein gp75, the human b (brown) locus product. Exp. Cell Res. 196:1991;233-240.
32. Abdel-Malek Z, Swope V, Smalara D, Babcock G, Dawes S, Nordlund J. Analysis of the UV-induced melanogenesis and growth arrest of human melanocytes. Pigment Cell Res. 7:1994;326-332.
33. Winder AJ, Harris H. Induction of tyrosinase in human melanoma cells by L-tyrosine phosphate and cytochalasin D. Exp. Cell. Res. 199:1992;248-254.
34. Thody AJ, Burchill SA. Tyrosinase and the regulation of coat color changes in C3H-HeAvy mice. Pigment Cell Res. 5:1992;335-339.
35. Burchill SA, Bennett DC, Holmes A, Thody AJ. Tyrosinase expression and melanogenesis in melanotic and amelanotic B16 mouse melanoma cells. Pathobiology. 9:1991;335-339.
36. Sabath DE, Broome HE, Prystowsky MB. Glyceraldehyde-3-phosphate dehydrogenase mRNA is a major interleukin 2-induced transcript in a cloned T-helper lymphocyte. Gene. 91:1990;185-191.
37. Desprez PY, Poujol D, Saez S. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH, E.C, 1.2.1.12.) gene expression in two malignant human mammary epithelial cell lines: BT-20 and MCF-7. Regulation of gene expression by 1,25-dihydroxyvitamin D3 (1,25-(OH)2D3). Cancer Lett. 64:1992;219-224.
38. Arita Y, O'Driscoll KR, Weinstein IB. Growth of human melanocyte cultures supported by 12-O-tetradecanoylphorbol-13-acetate is mediated through protein kinase C activation. Cancer Res. 52:1992;4514-4521.
39. Halaban R, Ghosh S, Duray P, Kirkwood JM, Lerner AB. Human melanocytes cultured from nevi and melanomas. J. Invest. Dermatol. 87:1986;95-101.
40. Herlyn M, Clark WH, Rodeck U, Mancianti ML, Jambrosic J, Koprowski H. Biology of tumor progression in human melanocytes. Lab. Invest. 56:1987;461-474.
41. Becker D, Beebe SJ, Herlyn M. Differential expression of protein kinase C and cAMP-dependent protein kinase in normal human melanocytes and malignant melanomas. Oncogene. 5:1990;1133-1139.
42. Coppock DL, Tansey JB, Nathanson L. 12-O-tetradecanoylphorbol 13-acetate induces transient cell cycle arrest in G1 and G2 in metastatic melanoma cells: inhibition of phosphorylation of p34 cdc2. Cell Growth and Differ. 3:1992;485-494.
43. Arita Y, O'Driscoll KR, Weinstein IB. Growth Inhibition of human melanoma-derived cells by 12-O-tetradecanoyl phorbol 13-acetate. Int. J. Cancer. 56:1994;229-235.
44. Dekker LV, Parker PJ. Protein kinase C-a question of specificity. Trends Biochem. Sci. 19:1994;73-77.
45. Yamanishi DT, Graham M, Buckmeier JA, Meyskens FL Jr. The differential expression of protein kinase C genes in normal human neonatal melanocytes and metastatic melanomas. Carcinogenesis. 12:1991;105-109.
46. Mischak H, Goodnight JA, Kolch W, Martiny-Baron G, Schaechtle C, Kazanietz MG, Blumberg PM, Pierce JH, Mushinski JF. Overexpression of protein kinase C-δ and -ε in NIH3T3 cells induces opposite effects on growth, morphology, anchorage dependence and tumourigenicity. J. Biol. Chem. 268:1993;6090-6096.
47. Assender JW, Kontny E, Fredholm BB. Expression of protein kinase C isoforms in smooth muscle cells in various states of differentiation. FEBS Lett. 342:1994;76-80.
48. Mischak H, Pierce JH, Goodnight J, Kazanietz MG, Blumberg PM, Mushinski JF. Phorbol ester-induced myeloid differentiation is mediated by protein kinase C-alpha and -delta and not by protein kinase C-beta II, -epsilon, -zeta, and -eta. J. Biol. Chem. 268:1993;20110-20115.
49. Belmont L, Mitchison T, Deacon HW. Catastrophic revelations about Op18/stathmin. Trends Biochem. Sci. 21:1996;197-198.
50. Larsson N, Melander H, Marklund U, Osterman O, Gullberg M. G2/M transition requires multisite phosphorylation of oncoprotein 18 by two distinct protein kinase systems. J. Biol. Chem. 270:1995;14175-14183.
51. 2+/calmodulin-dependent kinase IV/Gr-dependent phosphorylation of oncoprotein 18. Mol Cell Biol. 17:1997;3459-3467.
52. Belmont LD, Mitchison TJ. Identification of a protein that interacts with tubulin dimers and increases the catastrophe rate of microtubules. Cell. 84:1996;623-631.
53. Marklund U, Larsson N, Gradin MH, Brattsand G, Gullberg M. Oncoprotein 18 is a phosphorylation-responsive regulator of microtubule dynamics. EMBO J. 15:1996;5290-5298.
54. Di-Paolo G, Pellier V, Catsicas M, Antonsson B, Catsicas S, Grenningloh G. The phosphorylation of stathmin is essential for nerve growth factor-stimulated differentiation. J. Cell Biol. 133:1996;1383-1390.